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INTRODUCTION

CASE REPORT

Trans-catheter mitral valve replacement
(TMVR) remains in it’s infancy when compared
to trans-catheter aortic valve replacement
(TAVR). At present, TMVR is most commonly
performed in patients with degenerative native
valve disease with annular rigidity due to mitral
annular calcification (MAC) or patients with
bioprosthetic valve degeneration (Valve-inValve (ViV) replacement).1 Real-time, 3D TEE
guidance is typically used in these cases.2 We
present a case of a challenging ViV TMVR, in
which real-time 3D TEE was utilized.

The patient is a 71 year old woman with a history of rheumatic fever complicated
by mitral stenosis and atrial fibrillation who had previously undergone mitral valve
repair and radio frequency ablation in 2006 followed by a mitral valve
replacement (MVR), tricuspid valve repair and MAZE procedure in 2008. She
subsequently underwent a TAVR in 2016 due to symptomatic severe aortic
stenosis. In the ensuing years, she developed progressive shortness of breath
and severe dyspnea on exertion, requiring home oxygen therapy. An
echocardiogram demonstrated severe prosthetic mitral stenosis along with
severe pulmonary hypertension with a PA systolic pressure of 115 mmHg.
Given her high risk for surgery, the decision was made to treat her with a ViV
TMVR. After induction of general anesthesia (GA) and initiation of treatment with
nitric oxide (NO) a trans-septal approach was initially attempted. Through 3D
TEE imaging and guidance, a trans-septal approach was deemed to be both
high-risk and technically challenging due to the previous trans-septal approach to
her MVR along with significant intra-atrial septal wall calcification. The transapical approach to her MVR was subsequently pursued. Using 3D TEE
guidance, a balloon-expandable bioprosthetic trans-catheter valve was
positioned and successfully deployed. Post-procedural transvalvular gradients
were 3mmHg along with trivial paravalvular regurgitation. Post-procedure, her
PA systolic pressures had declined to 55mmHg. She was taken to the ICU
intubated, the NO was weaned and she was extubated. She was discharged to
home on POD #5.

DISCUSSION
TEE guidance with 3D imaging was
invaluable in this case. The use of TEE
guidance in the trans-septal attempt
resulted in the safest outcome for the
patient, as it was determined that the
septum could not be crossed in a safe
location that would result in a successful
deployment of the valve due to alteration of
the septal anatomy by her previous surgical
procedures. TEE guidance in the transapical attempt resulted in successful
positioning and deployment of the valve.

CONCLUSION
The use of TEE, and in particular 3D TEE, by skilled
echocardiographers is essential to the success of
TMR.
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Figure 1 Trans-septal attempt
Figure 2 Wire through surgical mitral valve

